Sintx Technologies (SINT) Shares Outstanding (Diluted Average) (2018 - 2026)
Sintx Technologies (SINT) recorded quarterly Shares Outstanding (Diluted Average) of $4.0 million in Q1 2026, up 44.73% quarter-over-quarter from $2.8 million in Q4 2025, and up 126.23% on a YoY basis from $1.8 million in Q1 2025.
Sintx Technologies (SINT) Shares Outstanding (Diluted Average) (2018 - 2026) Analysis & Trends
Sintx Technologies' Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 126.23% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 126.23% YoY), while the FY2025 annual figure was $2.8 million, up 272.39% from the prior year.
- Shares Outstanding (Diluted Average) was $4.0 million for Q1 2026 at Sintx Technologies, up from $2.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $4.0 million in Q1 2026 to a low of $16413.0 in Q2 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $1.1 million across 5 years, with a median of $656468.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) plunged 99.0% in 2022, then soared 4151.92% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $317323.0 in 2022, then plunged by 93.13% to $21786.0 in 2023, then jumped by 3318.63% to $744782.0 in 2024, then jumped by 272.39% to $2.8 million in 2025, then jumped by 44.73% to $4.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $4.0 million (Q1 2026), $2.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Sintx Technologies | 8.59 Mn | 6.70 Mn | 144,000.00 | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 744,782.00 |
| Sep 30, 2024 | 656,468.00 |
| Jun 30, 2024 | 697,868.00 |
| Mar 31, 2024 | 172,304.00 |
| Dec 31, 2023 | 21,786.00 |
| Sep 30, 2023 | 17,642.00 |
| Jun 30, 2023 | 16,413.00 |
| Mar 31, 2023 | 2.56 Mn |
| Dec 31, 2022 | 317,323.00 |
| Sep 30, 2022 | 250,870.00 |
| Jun 30, 2022 | 250,806.00 |
| Mar 31, 2022 | 247,122.00 |
| Dec 31, 2021 | 250,701.00 |
| Sep 30, 2021 | 25.10 Mn |
| Jun 30, 2021 | 24.68 Mn |